24-Month Clinical results for Healionics’ STARgraft featured at CiDA conference
/
DateNov 04 2025
SEATTLE, WA, UNITED STATES, November 3, 2025 /EINPresswire.com/ — Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced the presentation of 24-month clinical... Read More →


















